Key regions: Brazil, India, United Kingdom, Germany, China
The Digestives & Intestinal Remedies market in Asia is experiencing significant growth and development in recent years. Customer preferences in the Digestives & Intestinal Remedies market in Asia are shifting towards natural and herbal remedies. Consumers are increasingly seeking products that are made from natural ingredients and have fewer side effects. This preference for natural remedies is driven by a growing awareness of the potential harmful effects of synthetic drugs and a desire for more holistic approaches to healthcare. In addition, there is a cultural preference for traditional medicine in many Asian countries, which further fuels the demand for natural and herbal remedies in the Digestives & Intestinal Remedies market.Trends in the Digestives & Intestinal Remedies market in Asia include the rise of probiotics and digestive enzymes. Probiotics are live bacteria and yeasts that are beneficial for digestive health, and their popularity has been growing rapidly in recent years. Digestive enzymes, on the other hand, are substances that help break down food and improve digestion. These trends are driven by increasing awareness of the importance of gut health and the role it plays in overall well-being. Local special circumstances in the Digestives & Intestinal Remedies market in Asia include the prevalence of traditional medicine and the influence of cultural beliefs and practices. Traditional medicine, such as Ayurveda in India and Traditional Chinese Medicine in China, has a long history in Asia and continues to be widely practiced. This creates a unique market for Digestives & Intestinal Remedies, as consumers often seek out traditional remedies and treatments. Cultural beliefs and practices also play a role in shaping the market, as certain foods and herbs are believed to have specific digestive benefits in different Asian cultures.Underlying macroeconomic factors that contribute to the development of the Digestives & Intestinal Remedies market in Asia include the growing middle class and increasing disposable incomes. As more people in Asia move into the middle class, they have more disposable income to spend on healthcare products, including Digestives & Intestinal Remedies. In addition, the aging population in many Asian countries is driving demand for digestive health products, as older adults are more likely to experience digestive issues and seek remedies for them.In conclusion, the Digestives & Intestinal Remedies market in Asia is developing rapidly due to shifting customer preferences towards natural remedies, the rise of probiotics and digestive enzymes, the prevalence of traditional medicine, cultural beliefs and practices, and underlying macroeconomic factors such as the growing middle class and aging population.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
